Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 1430Sesión 2025

Prescription drugs; prohibit licensing boards from prohibiting practitioners from prescribing for off-label use.

Current version

El texto subrayado se agregaría a la ley vigente. El texto tachado se eliminaría.

MISSISSIPPI LEGISLATURE

2025 Regular Session

To: Public Health and Human Services

By: Representatives Currie, Hale

House Bill 1430

AN ACT TO PROHIBIT THE STATE BOARD OF MEDICAL LICENSURE AND THE MISSISSIPPI BOARD OF NURSING FROM ADOPTING ANY RULE OR POLICY OR TAKING ANY OTHER ACTION THAT PROHIBITS PHYSICIANS OR ADVANCED PRACTICE REGISTERED NURSES FROM PRESCRIBING DRUGS OR MEDICATIONS FOR OFF-LABEL USE; TO PROHIBIT THE STATE BOARD OF PHARMACY FROM ADOPTING ANY RULE OR POLICY OR TAKING ANY OTHER ACTION THAT PROHIBITS PHARMACISTS FROM FILLING PRESCRIPTIONS WRITTEN BY LICENSED PRACTITIONERS FOR OFF-LABEL USE; TO PROHIBIT THE MISSISSIPPI BOARD OF NURSING FROM ADOPTING ANY RULE OR POLICY OR TAKING ANY OTHER ACTION THAT PROHIBITS ADVANCED PRACTICE REGISTERED NURSES FROM PRESCRIBING SEMAGLUTIDE; AND FOR RELATED PURPOSES.

     BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MISSISSIPPI:

     SECTION 1.  (1)  As used in this section, the term "off-label use" means prescribing drugs or medications for indications, or using a dosage or dosage form, that have not been approved by the United States Food and Drug Administration.  The term "medications" in this definition includes compounding medications.

     (2)  The State Board of Medical Licensure shall not adopt any rule or policy or take any other action that prohibits physicians from prescribing drugs or medications for off-label use.

     (3)  The Mississippi Board of Nursing shall not adopt any rule or policy or take any other action that prohibits advanced practice registered nurses from prescribing drugs or medications for off-label use.

     (4)  The State Board of Pharmacy shall not adopt any rule or policy or take any other action that prohibits pharmacists from filling prescriptions written by licensed practitioners for off-label use.

     SECTION 2.  The Mississippi Board of Nursing shall not adopt any rule or policy or take away other action that prohibits advanced practice registered nurses from prescribing semaglutide under any brand name or in a generic formula.

     SECTION 3.  This act shall take effect and be in force from and after July 1, 2024.

Texto oficial de la Legislatura de Mississippi. El formato se adaptó para leerlo en Ratifi.